Following the U.S. Food and Drug Administration’s (FDA) amendment to the Emergency Use Authorization (EUA) on March 14, 2023, healthcare providers gained the ability to administer a Pfizer-BioNTech COVID-19 bivalent booster dose to certain pediatric patients. In response, the American Medical Association (AMA) released a new CPT® code on March 17, 2023, to accurately report […]